A Seattle-based biotech company is turning heads on Wednesday morning after it was announced that the company received a US patent for its respiratory tract delivery of levodopa...

To read the full story on AllPennyStocks.com, click here.

Impel Pharmaceuticals (NASDAQ:IMPL)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Impel Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Impel Pharmaceuticals (NASDAQ:IMPL)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Impel Pharmaceuticals 차트를 더 보려면 여기를 클릭.